1157 related articles for article (PubMed ID: 17711899)
21. Antiphospholipid antibodies and renal involvement.
Gigante A; Gasperini ML; Cianci R; Barbano B; Giannakakis K; Di Donato D; Fuiano G; Amoroso A
Am J Nephrol; 2009; 30(5):405-12. PubMed ID: 19713697
[TBL] [Abstract][Full Text] [Related]
22. High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus.
Ruiz-Irastorza G; Egurbide MV; Ugalde J; Aguirre C
Arch Intern Med; 2004 Jan; 164(1):77-82. PubMed ID: 14718326
[TBL] [Abstract][Full Text] [Related]
23. Pediatric antiphospholipid antibodies and antiphospholipid syndrome.
Hunt BJ
Semin Thromb Hemost; 2008 Apr; 34(3):274-81. PubMed ID: 18720307
[TBL] [Abstract][Full Text] [Related]
24. [Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome].
Reshetniak TM; Seredavkina nV; Mach ES; Aleksandrova EN; Novikov AA; Cherkasova MV; Nasonov EL
Ter Arkh; 2008; 80(10):60-7. PubMed ID: 19105418
[TBL] [Abstract][Full Text] [Related]
25. The Italian Registry of Antiphospholipid Antibodies.
Finazzi G
Haematologica; 1997; 82(1):101-5. PubMed ID: 9107095
[TBL] [Abstract][Full Text] [Related]
26. Antiphospholipid syndrome in systemic lupus erythematosus: is the whole greater than the sum of its parts?
Laskin CA; Clark CA; Spitzer KA
Rheum Dis Clin North Am; 2005 May; 31(2):255-72, vi. PubMed ID: 15922145
[TBL] [Abstract][Full Text] [Related]
27. Antibodies to phosphatidylethanolamine as the only antiphospholipid antibodies found in patients with unexplained thromboses.
Sanmarco M; Alessi MC; Harle JR; Sapin C; Aillaud MF; Gentile S; Juhan-Vague I; Weiller PJ
Thromb Haemost; 2001 May; 85(5):800-5. PubMed ID: 11372671
[TBL] [Abstract][Full Text] [Related]
28. Risk of thrombosis in patients with antiphospholipid antibodies and factor V Leiden mutation.
Pablos JL; Caliz RA; Carreira PE; Atsumi T; Serrano L; Amengual O; Santiago B; Khamashta MA; Hughes GR; Gomez-Reino JJ
J Rheumatol; 1999 Mar; 26(3):588-90. PubMed ID: 10090167
[TBL] [Abstract][Full Text] [Related]
29. How to manage patients with systemic lupus erythematosus who are also antiphospholipid antibody positive.
Giles I; Rahman A
Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):525-37. PubMed ID: 19591782
[TBL] [Abstract][Full Text] [Related]
30. Association of STAT4 and BLK, but not BANK1 or IRF5, with primary antiphospholipid syndrome.
Yin H; Borghi MO; Delgado-Vega AM; Tincani A; Meroni PL; Alarcón-Riquelme ME
Arthritis Rheum; 2009 Aug; 60(8):2468-71. PubMed ID: 19644876
[TBL] [Abstract][Full Text] [Related]
31. [Antiphospholipid syndrome--the description of two cases].
Podrazilová L; Peterová V; Olejárová M; Seidl Z; Dostál C
Vnitr Lek; 2006 Jan; 52(1):89-94. PubMed ID: 16526206
[TBL] [Abstract][Full Text] [Related]
32. [Antiphospholipid antibody/cofactors. What are they? Why, when and how to search for them? Is treatment justified?].
Piette JC; Papo T; Amoura Z; Boffa MC
Ann Med Interne (Paris); 1996; 147(7):492-7. PubMed ID: 9092360
[TBL] [Abstract][Full Text] [Related]
33. [Systemic lupus erythematosus and antiphospholipid syndrome].
Gröne HJ
Verh Dtsch Ges Pathol; 1996; 80():21-37. PubMed ID: 9065004
[TBL] [Abstract][Full Text] [Related]
34. Antiphospholipid antibodies and migraine: a retrospective study of 428 patients with inflammatory connective tissue diseases.
Tănăsescu R; Nicolau A; Caraiola S; Ticmeanu M; Cojocaru IM; Frăsineanu A; Ionescu R; Hristea A; Ene A; Anghel D; Tănăsescu R; Băicuş C
Rom J Intern Med; 2007; 45(4):355-63. PubMed ID: 18767411
[TBL] [Abstract][Full Text] [Related]
35. Clinical manifestations of the antiphospholipid syndrome.
Alarcón-Segovia D
J Rheumatol; 1992 Nov; 19(11):1778-81. PubMed ID: 1491400
[TBL] [Abstract][Full Text] [Related]
36. The clinical spectrum of antiphospholipid syndrome.
Baker WF; Bick RL
Hematol Oncol Clin North Am; 2008 Feb; 22(1):33-52, v-vi. PubMed ID: 18207064
[TBL] [Abstract][Full Text] [Related]
37. New targeted therapies for treatment of thrombosis in antiphospholipid syndrome.
Pierangeli SS; Vega-Ostertag ME; González EB
Expert Rev Mol Med; 2007 Nov; 9(30):1-15. PubMed ID: 17997880
[TBL] [Abstract][Full Text] [Related]
38. Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome.
Lopez LR; Dier KJ; Lopez D; Merrill JT; Fink CA
Am J Clin Pathol; 2004 Jan; 121(1):142-9. PubMed ID: 14750252
[TBL] [Abstract][Full Text] [Related]
39. Antiphospholipid syndrome.
Gezer S
Dis Mon; 2003 Dec; 49(12):696-741. PubMed ID: 14679358
[TBL] [Abstract][Full Text] [Related]
40. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
